Shield Therapeutics (LSE:STX) Days Inventory : 181.71 (As of Jun. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Shield Therapeutics Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Shield Therapeutics's Average Total Inventories for the six months ended in Jun. 2023 was £2.08 Mil. Shield Therapeutics's Cost of Goods Sold for the six months ended in Jun. 2023 was £2.09 Mil. Hence, Shield Therapeutics's Days Inventory for the six months ended in Jun. 2023 was 181.71.

The historical rank and industry rank for Shield Therapeutics's Days Inventory or its related term are showing as below:

LSE:STX' s Days Inventory Range Over the Past 10 Years
Min: 137.32 Med: 397.74 Max: 1525.7
Current: 198.56

During the past 9 years, Shield Therapeutics's highest Days Inventory was 1525.70. The lowest was 137.32. And the median was 397.74.

LSE:STX's Days Inventory is ranked worse than
65.98% of 973 companies
in the Drug Manufacturers industry
Industry Median: 157.9 vs LSE:STX: 198.56

Shield Therapeutics's Days Inventory declined from Jun. 2022 (244.99) to Jun. 2023 (181.71).

Inventory Turnover measures how fast the company turns over its inventory within a year. Shield Therapeutics's Inventory Turnover for the six months ended in Jun. 2023 was 1.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Shield Therapeutics's Inventory-to-Revenue for the six months ended in Jun. 2023 was 0.48.

Shield Therapeutics Days Inventory Historical Data

The historical data trend for Shield Therapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shield Therapeutics Days Inventory Chart

Shield Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Inventory

Get a 7-Day Free Trial

137.32

397.74

313.65

561.28

228.46

Shield Therapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Days Inventory	Get a 7-Day Free Trial													624.76	492.33	244.99	197.45	181.71

Competitive Comparison of Shield Therapeutics's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Shield Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shield Therapeutics's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shield Therapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Shield Therapeutics's Days Inventory falls into.

Shield Therapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Shield Therapeutics's Days Inventory for the fiscal year that ended in Dec. 2022 is calculated as

	Days Inventory (A: Dec. 2022 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2021 )	+	Total Inventories (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (1.635	+	1.457)	/	2 )	/	2.47	*	365
=	1.546					/	2.47	*	365
=	228.46

Shield Therapeutics's Days Inventory for the quarter that ended in Jun. 2023 is calculated as:

	Days Inventory (Q: Jun. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Dec. 2022 )	+	Total Inventories (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (1.457	+	2.695)	/	2 )	/	2.085	*	365 / 2
=	2.076					/	2.085	*	365 / 2
=	181.71

Shield Therapeutics (LSE:STX) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Shield Therapeutics's Inventory Turnover for the six months ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	2.085	/	2.076
	=	1.00

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Shield Therapeutics's Inventory to Revenue for the six months ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	2.076	/	4.334
	=	0.48

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Shield Therapeutics Days Inventory Related Terms

Thank you for viewing the detailed overview of Shield Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Shield Therapeutics (LSE:STX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shield Therapeutics PLC (LSE:STX) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

SHIEF:USA 1JS:Germany

Address

Northern Design Centre, Baltic Business Quarter, Gateshead Quays, Newcastle, GBR, NE8 3DF

Website

https://www.shieldtherapeutics.com

Shield Therapeutics PLC is a specialty pharmaceutical company focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals which address areas of high unmet medical need. The company's operating segments are based on key products including Accrufer/Feraccru, used as a novel oral treatment for iron deficiency anemia in patients, which is commercially available, and PT20 used in treating hyperphosphatemia, which is in its last stage of completion. The company generates maximum revenue from Feraccru segment.